Leukaemia

Medical Encyclopedia › L › Leukaemia

Canceralso: leukemia, blood cancer, AML, ALL, CML, CLL

Leukaemia is a cancer of the blood-forming cells in the bone marrow. Large numbers of immature or non-functioning white blood cells are produced and crowd out normal blood formation. Acute forms develop quickly and need immediate treatment, while chronic forms often progress slowly. Treatment is tailored precisely to the subtype.

Overview

There are four main types: acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML) and chronic lymphocytic leukaemia (CLL). ALL is the most common cancer in children, and CLL the most common leukaemia in older adults in Europe.

Symptoms

Acute leukaemias develop over days to weeks. Because healthy blood cells are lacking, tiredness, pallor and breathlessness from anaemia occur, as well as frequent or severe infections with fever. A lack of platelets (thrombocytopenia) shows as unexplained bruising, pinpoint skin bleeds (petechiae), nosebleeds or bleeding gums. Bone pain, swollen lymph nodes and an enlarged spleen can also occur. Chronic leukaemias often cause no symptoms at first and are found by chance on a blood test; later, night sweats, weight loss and reduced fitness may appear.

Causes and risk factors

In most cases no cause is found. Known risk factors are ionising radiation, benzene, smoking, previous chemotherapy or radiotherapy and certain inherited conditions such as Down syndrome.

Diagnosis

A full blood count with differential gives clues: the white cell count may be very high but also low, and immature cells are often seen. The diagnosis is confirmed by a bone marrow biopsy. Specialised tests of the cells and their genes define the exact subtype, such as the Philadelphia chromosome in CML, which is crucial for treatment planning.

Treatment

Acute leukaemias are treated in specialist centres with intensive chemotherapy, plus targeted medicines and, with a high relapse risk, stem cell transplantation. CAR T-cell therapy is an option for certain forms of ALL. In CML, tablets such as imatinib block the altered enzyme and can keep the disease under control for a long time in many people. Early CLL without symptoms is often just monitored and treated when symptoms or blood count changes appear.

Outlook

The outlook depends strongly on subtype, genetic features, age and general health. With modern treatment it has improved markedly for many forms, especially for children with ALL.

Frequently asked questions

What are the first signs of leukaemia?

Common are tiredness and pallor, frequent infections, fever, unexplained bruising and bleeding gums or nosebleeds. These usually have harmless causes but should be checked if they persist.

Can a blood test detect leukaemia?

The blood count is usually abnormal in leukaemia and gives important clues. The diagnosis is confirmed and classified by examining the bone marrow.

Is leukaemia hereditary?

As a rule, no. The genetic changes usually arise during life in the blood cells. Family clusters are rare.

Related terms

Test your knowledge: questions on blood, cancer and laboratory tests – from beginner to exam level.

Go to the Medical Quiz

Sources

  • Döhner H et al.: Diagnosis and management of AML in adults – 2022 recommendations from an international expert panel on behalf of the ELN (Blood, 2022)
  • Onkopedia guidelines on acute myeloid, chronic myeloid and chronic lymphocytic leukaemia (German Society of Haematology and Medical Oncology, DGHO)
  • S3 guideline Diagnosis, treatment and follow-up of patients with chronic lymphocytic leukaemia (German Guideline Programme in Oncology; AWMF)

This entry is for general information only and does not replace medical advice. Last updated: November 2026.